Familial B-cell Lymphoproliferative Disorders

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-06-30

Study Completion Date

2040-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study investigates families with at least two cases of B-cell lymphoproliferative disorders (LPD), and evaluates the prevalence of LPD in families, the relationship between medical history, genetic factors, and the risk of familial LPD, and various clinical outcomes for these families in a multiethnic population of Jews and Arabs in Israel.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL)

NCT06416267

Monoclonal B-Cell Lymphocytosis Chronic Lymphocytic Leukemia Infections +6 more

NOT_YET_RECRUITING

Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission?

NCT03681938

Lymphoma, B-Cell

UNKNOWN

A Study of SHR-A1912 for Injection in Patients With B Cell Lymphomas

NCT05113069

B Cell Lymphoma

ENROLLING_BY_INVITATION PHASE1

Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia

NCT02618109

B Acute Lymphoblastic Leukemia Leukemia Relapse

TERMINATED PHASE4

Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)

NCT00923507

Waldenstrom Macroglobulinemia Lymphoplasmacytic Lymphoma Monoclonal B-Cell Lymphocytosis +2 more

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lymphoproliferative Disorders Premalignant Monoclonal B-Cell Lymphocytosis Chronic Lymphocytic Leukemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

FAMILY_BASED

Study Time Perspective

OTHER

No intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients must have LPD and must have a family history of LPD. LPD patients who signed an informed consent to participate in the study.

Criteria for the inclusion of relatives of patients:

Relatives must be related by blood to LPD patients or unrelated (for control group).

Relatives who signed an informed consent to participate in the study.